The platform will undergo maintenance on Sep 14 at about 7:45 AM EST and will be unavailable for approximately 2 hours.
1997
DOI: 10.1007/s002770050333
|View full text |Cite
|
Sign up to set email alerts
|

Proliferative effect of postapheresis platelet donor plasma on a megakaryoblastic leukemia cell line

Abstract: Platelet donors sometimes show an increased platelet count following apheresis. We analyzed the effect of plasma obtained from such donors, along with thrombopoietin (Tpo), for growth and differentiation-inducing activity on a megakaryoblastic leukemia cell line, Meg-J. Colony formation was stimulated by donor plasma for Meg-J cells in a dose-dependent manner, and the time course of the sampling peaked 1 day after apheresis. Neither the donor plasma nor Tpo induced morphological differentiation. Donor plasma f… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2001
2001
2001
2001

Publication Types

Select...
1
1

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 22 publications
(21 reference statements)
0
1
0
Order By: Relevance
“…Administration of recombinant TPO has been shown to greatly increase the number of circulating CFU‐Mk in patients with cancer [7]. Plasma obtained from platelet donors 1 day after apheresis stimulated growth rather than induced differentiation of a megakaryoblastic cell line [8]. On the other hand, other thrombopoietic growth factors, such as IL‐6 and IL‐1β[1], remain unchanged following plateletpheresis.…”
Section: Discussionmentioning
confidence: 99%
“…Administration of recombinant TPO has been shown to greatly increase the number of circulating CFU‐Mk in patients with cancer [7]. Plasma obtained from platelet donors 1 day after apheresis stimulated growth rather than induced differentiation of a megakaryoblastic cell line [8]. On the other hand, other thrombopoietic growth factors, such as IL‐6 and IL‐1β[1], remain unchanged following plateletpheresis.…”
Section: Discussionmentioning
confidence: 99%